New Delhi, 27 Oct 2024: The Delhi High Court has ordered in favour of the Registrar of Trade Mark's decision to refuse the objection of drug major Abbott against approving a trademark Mebufen for Himachal Pradesh-based Meridian Medicare's pain killer drug.

Abbott raise......
View Details

Related News

• Absconding accused in banned nitrazepam tablets and codeine-containing cough syrup case arrested (28-10-2024)

---

• Private hospitals in UP will not be able to sell medicines of their choice (28-10-2024)

---

• BCI removes 107 fake advocates from Delhi roll (27-10-2024)

---

• Rewa police action against narcotic cough syrup, seized goods worth Rs 7 lakhs (27-10-2024)

---

• FDA seizes ₹1 crore stock for misleading claims (27-10-2024)

---

• One more case of making 12th pass as doctor has come to light again in Rajasthan (26-10-2024)

---

• 9 arrested in Excise Department action, 1500 bottles of cough syrup and four wheeler recovered (26-10-2024)

---

• Fake medicine were being made in toffee factory, Rs 80 crore Medicines sold in the market (26-10-2024)

---

• Centre issues revised list of refurbished medical equipment for import; industry reacts sharply (26-10-2024)

---

• Ensure Tamil university diploma holders don’t practise Siddha, Madras HC tells govt (26-10-2024)

---